Report cover image

Organ Transplant Immunosuppressant Drugs Market, By Drug Class (Calcineurin Inhibitors, Antiproliferative Agents, mTOR Inhibitor, Steroids, Antibodies), By Transplant Type (Kidney, Liver, Heart, Lung, Pancreas, Others), By Distribution Channel (Hospital P

Publisher Coherent Market Insights
Published Mar 21, 2025
Length 176 Pages
SKU # CMI20004654

Description

After a successful organ transplant, you may have to take immunosuppressant drugs. These drugs help your immune system from attacking (rejecting) the new organ from which it has been transplanted. In general, they should be taken for your lifetime, or until the treatments are complete. Orally, or injected into a vein, these drugs work by stopping your body's immune cells from further attacking your transplanted organ. They also control your allergic reactions to the transplanted organ and reduce inflammation around the transplanted tissues.

Market Dynamics:

Approval and launch of new drugs is expected to propel growth of the global organ transplant immunosuppressant drugs market over the forecast period. For instance, in July 2021, Kadmon Holdings, Inc. received the U.S. Food and Drug Administration approval for REZUROCK (belumosudil) for the treatment of adult and pediatric patients with chronic graft-versus-host disease.

Negative outcomes in clinical trials is expected to hinder growth of the global organ transplant immunosuppressant drugs market. For instance, in September 2021, Novartis AG announced to halt a mid-stage clinical trial of drug intended to prevent organ rejection after an early look at data in kidney transplant patients showed the experimental treatment was less effective compared to the standard of care therapy.

The market is witnessing several M&A activities. For instance, in September 2021, Sanofi announced to acquire Kadmon Holdings, a U.S.-based biopharmaceutical company.

Key features of the study:
  • This report provides in-depth analysis of the global organ transplant immunosuppressant drugs market, and provides market size (US$ Billion) and compound annual growth rate (CAGR%) for the forecast period 2025-2032, considering 2024 as the base year
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
  • It profiles key players in the global organ transplant immunosuppressant drugs market based on the following parameters – company highlights, products portfolio, key highlights, financial performance, and strategies
  • Key companies covered as a part of this study include Astellas Pharma, Genzyme Corporation, Accord Healthcare Ltd., Watson Pharmaceuticals, Inc., Novartis AG, Mylan Laboratories, Inc., GlaxoSmithKline plc., Belcher Pharmaceuticals LLC, Leo Pharma As, Glenmark Pharmaceuticals Ltd., TFF Pharmaceuticals, Inc., TolerogenixX GmbH, Veloxis Pharmaceuticals Inc., Dr. Reddy’s Laboratories Ltd., Panacea Biotec Ltd., Strides Pharma Global Pte Ltd., and Hoffman La Roche Ltd.
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
  • The global organ transplant immunosuppressant drugs market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global organ transplant immunosuppressant drugs market
Detailed Segmentation:
  • Global Organ Transplant Immunosuppressant Drugs Market, By Drug Class:
  • Calcineurin Inhibitors
  • Antiproliferative Agents
  • mTOR Inhibitor
  • Steroids
  • Antibodies
  • Global Organ Transplant Immunosuppressant Drugs Market, By Transplant Type:
  • Kidney
  • Liver
  • Heart
  • Lung
  • Pancreas
  • Others
  • Global Organ Transplant Immunosuppressant Drugs Market, By Distribution Channel:
  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies
  • Global Organ Transplant Immunosuppressant Drugs Market, By Region:
  • North America
  • Latin America
  • Europe
  • Asia Pacific
  • Middle East
  • Africa
  • Company Profiles
  • Astellas Pharma
  • Genzyme Corporation
  • Accord Healthcare Ltd.
  • Watson Pharmaceuticals, Inc.
  • Novartis AG
  • Mylan Laboratories, Inc.
  • GlaxoSmithKline plc.
  • Belcher Pharmaceuticals LLC
  • Leo Pharma AS
  • Glenmark Pharmaceuticals Ltd.
  • TFF Pharmaceuticals, Inc.
  • TolerogenixX GmbH
  • Veloxis Pharmaceuticals Inc.
  • Reddy’s Laboratories Ltd.
  • Panacea Biotec Ltd.
  • Strides Pharma Global Pte Ltd.
  • F-Hoffman La Roche

Table of Contents

176 Pages
1. Research Objectives and Assumptions
Research Objectives
Assumptions
Abbreviations
2. Market Purview
Report Description
Market Definition and Scope
Executive Summary
Market Snippet, By Drug Class
Market Snippet, By Transplant Type
Market Snippet, By Distribution Channel
Market Snippet, By Region
Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
Market Dynamics
Drivers
Restraints
Opportunities
Recent Trends
Merger, Acquisition, and Collaborations
Regulatory Scenario
Key Developments
PEST Analysis
PORTER’s Analysis
4. Global Organ Transplant Immunosuppressant Drugs Market - COVID-19 Impact Analysis
Economic Impact
COVID-19 Epidemiology
Impact on Supply and Demand
5. Global Organ Transplant Immunosuppressant Drugs Market, By Drug Class, 2020 - 2032, (US$ Bn)
Introduction
Market Share Analysis, 2025 and 2032 (%)
Y-o-Y Growth Analysis, 2021 - 2032
Segment Trends
Calcineurin Inhibitors
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020 - 2032, (US$ Bn)
Segment Trends
Antiproliferative Agents
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020 - 2032, (US$ Bn)
Segment Trends
mTOR Inhibitor
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020 - 2032, (US$ Bn)
Segment Trends
Steroids
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020 - 2032, (US$ Bn)
Segment Trends
Antibodies
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020 - 2032, (US$ Bn)
Segment Trends
6. Global Organ Transplant Immunosuppressant Drugs Market, By Transplant Type, 2020 - 2032, (US$ Bn)
Introduction
Market Share Analysis, 2025 and 2032 (%)
Y-o-Y Growth Analysis, 2021 - 2032
Segment Trends
Kidney
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020 - 2032, (US$ Bn)
Segment Trends
Liver
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020 - 2032, (US$ Bn)
Segment Trends
Heart
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020 - 2032, (US$ Bn)
Segment Trends
Lung
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020 - 2032, (US$ Bn)
Segment Trends
Pancreas
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020 - 2032, (US$ Bn)
Segment Trends
Others
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020 - 2032, (US$ Bn)
Segment Trends
7. Global Organ Transplant Immunosuppressant Drugs Market, By Distribution Channel, 2020 - 2032, (US$ Bn)
Introduction
Market Share Analysis, 2025 and 2032 (%)
Y-o-Y Growth Analysis, 2021 - 2032
Segment Trends
Hospital Pharmacies
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020 - 2032, (US$ Bn)
Retail Pharmacies
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020 - 2032, (US$ Bn)
Online Pharmacies
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020 - 2032, (US$ Bn)
8. Global Organ Transplant Immunosuppressant Drugs Market, By Region, 2020 - 2032, (US$ Bn)
Introduction
Market Share Analysis, 2025 and 2032 (%)
Y-o-Y Growth Analysis, 2021 - 2032
Segment Trends
North America
Market Size and Forecast, Y-o-Y Growth, By Drug Class, 2020 - 2032, (US$ Bn)
Market Size and Forecast, Y-o-Y Growth, By Transplant Type, 2020 –2032, (US$ Bn)
Market Size and Forecast, Y-o-Y Growth, By Distribution Channel, 2020–2032, (US$ Bn)
Market Size and Forecast, By Country, Y-o-Y Growth, By Country, 2020 –2032, (US$ Bn)
U.S.
Canada
Europe
Market Size and Forecast, Y-o-Y Growth, By Drug Class, 2020 - 2032, (US$ Bn)
Market Size and Forecast, Y-o-Y Growth, By Transplant Type, 2020 - 2032, (US$ Bn)
Market Size and Forecast, Y-o-Y Growth, By Distribution Channel, 2020 - 2032, (US$ Bn)
Market Size and Forecast, By Country, Y-o-Y Growth, By Country, 2020 -2032, (US$ Bn)
U.K.
Germany
Italy
France
Spain
Russia
Rest of Europe
Asia Pacific
Market Size and Forecast, Y-o-Y Growth, By Drug Class, 2020 - 2032, (US$ Bn)
Market Size and Forecast, Y-o-Y Growth, By Transplant Type, 2020 - 2032, (US$ Bn)
Market Size and Forecast, Y-o-Y Growth, By Distribution Channel, 2020 -2032, (US$ Bn)
Market Size and Forecast, By Country, Y-o-Y Growth, By Country, 2020 -2032, (US$ Bn)
China
India
Japan
ASEAN
Australia
South Korea
Rest of Asia Pacific
Latin America
Market Size and Forecast, Y-o-Y Growth, By Drug Class, 2020 - 2032, (US$ Bn)
Market Size and Forecast, Y-o-Y Growth, By Transplant Type, 2020 - 2032, (US$ Bn)
Market Size and Forecast, Y-o-Y Growth, By Distribution Channel, 2020 -2032, (US$ Bn)
Market Size and Forecast, By Country, Y-o-Y Growth, By Country, 2020 -2032, (US$ Bn)
Brazil
Mexico
Argentina
Rest of Latin America
Middle East
Market Size and Forecast, Y-o-Y Growth, By Drug Class, 2020 - 2032, (US$ Bn)
Market Size and Forecast, Y-o-Y Growth, By Transplant Type, 2020 - 2032, (US$ Bn)
Market Size and Forecast, Y-o-Y Growth, By Distribution Channel, 2020 -2032, (US$ Bn)
Market Size and Forecast, By Country, Y-o-Y Growth, By Country, 2020 -2032, (US$ Bn)
GCC
Israel
Rest of Middle East
Africa
Introduction
Market Size and Forecast, Y-o-Y Growth, By Drug Class, 2020 - 2032, (US$ Bn)
Market Size and Forecast, Y-o-Y Growth, By Transplant Type, 2020 - 2032, (US$ Bn)
Market Size and Forecast, Y-o-Y Growth, By Distribution Channel, 2020 - 2032, (US$ Bn)
Market Size and Forecast, By Country, Y-o-Y Growth, By Country, 2020 -2032, (US$ Bn)
North Africa
Central Africa
South Africa
9. Competitive Landscape
Company Profiles
Astellas Pharma
Company Overview
Product Portfolio
Key Highlights
Financial Overview
Strategies
Genzyme Corporation
Accord Healthcare Ltd.
Watson Pharmaceuticals, Inc.
Novartis AG
Mylan Laboratories, Inc.
GlaxoSmithKline plc.
Belcher Pharmaceuticals LLC
Leo Pharma As
Glenmark Pharmaceuticals Ltd.
TFF Pharmaceuticals, Inc.
TolerogenixX GmbH
Veloxis Pharmaceuticals Inc.
Dr. Reddy’s Laboratories Ltd.
Panacea Biotec Ltd.
Strides Pharma Global Pte Ltd.
Hoffman La Roche
Analysts’ Views
10. Section
References
Research Methodology
About us and Sales Contact
*Browse 32 market data tables and 28 figures on “Global Organ Transplant Immunosuppressant Drugs Market” - Global forecast to 2032

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us